Company intelligence / Profile preview

Levels

New York, New York, United Stateslevelsaudio.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Levels has launched a commercial digital health platform that integrates real-time continuous glucose monitoring with lifestyle tracking to provide actionable insights for users. The company is conducting large-scale research studies in collaboration with leading researchers to further validate its approach and expand the scientific understanding of metabolic patterns across diverse populations

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Device (Continuous glucose monitor integration)Digital biomarker monitoringNon-pharmacological therapy (lifestyle/diet intervention)
Industry: Digital Health Medical Devices

Partnerships

Collaborations with top academic researchers in metabolic health for IRB-approved studies

Beyond the preview

Go deeper on Levels.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Levels.

Explore the full profile